Lymphoma Cancer | Tumor

CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

Keytruda Improves Progression-Free Survival in Subset of Patients With Relapsed/Refractory Hodgkin Lymphoma

April 19th 2021

Median progression-free survival in patients treated with Keytruda was 13.2 months versus 8.3 months with Adcetris, which makes Keytruda an “effective treatment option” for patients in this population who were either ineligible for or relapsed after autologous hematopoietic stem cell transplantation.

How TikTok Helped One Survivor Discover Connection and Community

April 15th 2021

Lymphoma survivor Nina Luker talks about receiving a diagnosis at age 24 and how sharing her story with nearly 200,000 supporters on social media helped her find purpose.

Investigational Drug Shows Promise in Lymphoma Subsets

April 6th 2021

Early findings show that glofitamab may be a safe and effective option for patients with pretreated, relapsed/refractory B-cell non-Hodgkin lymphoma.

How a Handmade Care Package Inspired One Cancer ‘Alumni’ to Create ‘Kits to Heart’

March 25th 2021

In this episode of the “CURE® Talks Cancer” podcast, we spoke with a large B-cell lymphoma “alumni” who was diagnosed at 24 about what it was like to be the only young patient receiving infusions at her cancer center, and what led her to start a nonprofit organization to help others along their journey.

R-CHOP Plus Revlimid Shows Tolerable Safety Profile, But Does Not Improve Progression-Free Survival

March 22nd 2021

For patients with B-cell lymphoma, the addition of Revlimid to standard R-CHOP did not improve progression-free survival nor event-free survival.

How TikTok Helped One Cancer Survivor Find Connection and Community

March 11th 2021

This week on the “CURE® Talks Cancer” podcast, we spoke with lymphoma survivor Nina Luker about what it was like to receive a diagnosis at age 24, and how sharing her story with nearly 200,000 supporters on TikTok and Instagram led her to find purpose with the Lymphoma Research Foundation.

Cancer Survivor Offers Tips on How to Help Loved Ones Get Through Difficult Times

March 9th 2021

Nearly one year ago to the day, 24-year-old Nina Luker was completely blindsided by a diagnosis of non-Hodgkin lymphoma. But after powering through treatments in the thick of the COVID-19 pandemic, Luker is now cancer-free and offering advice to those who may be looking for ways to help their loved ones through difficult times of their own.

5 Recent Cancer Drug Approvals Patients May Have Missed

February 26th 2021

Throughout the winter, the FDA has continued to approve several new agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.

Above the Surface: A Discussion About Cutaneous T-Cell Lymphoma

February 20th 2021

As part of its Speaking Out video series, CURE® spoke with Dr. Steven M. Horwitz on behalf of the Cutaneous Lymphoma Foundation about cutaneous T-cell lymphoma and options for treatment.

Advocating for Herself Amid Treatment for a Rare Cancer

February 15th 2021

One patient with breast implant-associated anaplastic large cell lymphoma spoke out for herself throughout therapy — and encourages other patients do the same.

CAR-T Cell Therapy Receives FDA Approval to Treat Certain Types of Large B-Cell Lymphoma

February 5th 2021

The Food and Drug Administration on Friday approved Breyanzi, a cell-based gene therapy, for the treatment of adults with certain types of large B-cell lymphoma.

Outside of Treatment

January 19th 2021

Clinical Trials in Cutaneous T-Cell Lymphoma

January 19th 2021

Treatment Options for Cutaneous T-Cell Lymphoma

January 19th 2021

The Basics of Cutaneous T-Cell Lymphoma

January 19th 2021

Significant Number of Patients With Blood Cancers Deal With Depression or Anxiety Before or After Diagnosis, Highlighting ‘Critical’ Need for Mental Health Screening and Management

December 8th 2020

This data, according to a resident physician at Brigham and Women’s Hospital, highlights the need for systematic mental health screening and management for individuals with blood cancers.

Patients With Aggressive Lymphomas Experience Major Quality of Life Improvements 1 Year After Diagnosis

December 7th 2020

Patients with aggressive lymphomas experienced sharp increases in quality of life from time of diagnosis until one year later and continued to see improvements for almost a decade.

Poteligeo May Result in Antitumor Activity in Adult T-Cell Leukemia/Lymphoma

December 2nd 2020

Study results also determined that immune system status before treatment may predict outcomes post-treatment.

Smiling Through Cancer Treatment Amid the COVID-19 Pandemic

November 26th 2020

In this episode of the “CURE Talks Cancer” podcast, we spoke with a teenager who was diagnosed with Hodgkin lymphoma at the start of the COVID-19 pandemic. We talked about her cancer journey, what it was like to receive treatment during the pandemic, and more.

A Journey Through DLBCL: Cautiously Hopeful

November 25th 2020

Managing DLBCL: A Team Effort

November 25th 2020

CAR-T for Relapsed DLBCL: Advice for Patients & Caregivers

November 25th 2020

Relapsed DLBCL: Assessing Response to CAR-T

November 25th 2020

Relapsed DLBCL: Recovering After CAR-T

November 25th 2020

CAR-T for DLBCL During COVID-19: A Caregiver’s Experience

November 25th 2020

Relapsed DLBCL: CAR-T Cell Related Side Effects

November 25th 2020

CAR-T Cell Therapy for Relapsed/Refractory DLBCL

November 25th 2020

A DLBCL Relapse During COVID-19

November 25th 2020

A Patient’s Initial Treatment for DLBCL

November 25th 2020

A Diagnosis of Exclusion

November 25th 2020